Search Results - Gascó Hernández, Amaya

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

    Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma by Aggarwal, Charu, Saba, Nabil F, Algazi, Alain, Sukari, Ammar, Seiwert, Tanguy Y, Haigentz, Missak, Porosnicu, Mercedes, Bonomi, Marcelo, Boyer, Jean, Esser, Mark T, Cheng, Lily I, Agrawal, Sonia, Jennings, Emily C, Durham, Nicholas M, Fraser, Karl, Lissa, Delphine, Gong, Maozhen, Ceaicovscaia, Natalia, Gascó Hernández, Amaya, Kumar, Rakesh

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity

    Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity by Smith, Alison E, Chan, Stacia, Wang, Zhiyong, McCloskey, Asako, Reilly, Quinn, Wang, Jayden Z, Patel, Hetika Vora, Koshizuka, Keiichi, Soifer, Harris S, Kessler, Linda, Dayoub, Ashley, Villaflor, Victoria, Adkins, Douglas R, Bruce, Justine Y, Ho, Alan L, Perez, Cesar A, Hanna, Glenn J, Gascó Hernández, Amaya, Saunders, Andrew, Dale, Stephen, Gutkind, J Silvio, Burrows, Francis, Malik, Shivani

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A View on Drug Development for Cancer Prevention

    A View on Drug Development for Cancer Prevention by Reynolds, Andrew R, Moschetta, Michele, Yohannes, Alula R, Walcott, Farzana, Ashford, Marianne, Szucs, Zoltan, Sarbajna, Tina, Hadfield, James, Harrison, Eden, Challis, Benjamin G, Hernandez, Amaya Gasco, Schiavon, Gaia, Germa, Caroline, Zorenyi, Gyorgy, Crean, Barry, Galbraith, Susan

    Published in Cancer discovery
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03

    Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed... by Planchard, David, Brahmer, Julie R., Yang, James C., Chen, Yuh-Min, Lee, Kang-Yun, Suksombooncharoen, Thatthan, Viglianti, Natasha, Gustavson, Mark, Ragone, Alejandra, Hernandez, Amaya Gasco

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors

    BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors by Bertran-Alamillo, Jordi, Giménez-Capitán, Ana, Román, Ruth, Talbot, Sara, Whiteley, Rebecca, Floc'h, Nicolas, Martínez-Pérez, Elizabeth, Martin, Matthew J, Smith, Paul D, Sullivan, Ivana, Terp, Mikkel G, Saeh, Jamal, Marino-Buslje, Cristina, Fabbri, Giulia, Guo, Grace, Xu, Man, Tornador, Cristian, Aguilar-Hernández, Andrés, Reguart, Noemí, Ditzel, Henrik J, Martínez-Bueno, Alejandro, Nabau-Moretó, Núria, Gascó, Amaya, Rosell, Rafael, Pease, J Elizabeth, Polanska, Urszula M, Travers, Jon, Urosevic, Jelena, Molina-Vila, Miguel A

    Published in Molecular cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: